Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.19 | 2e-06 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 1e-05 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0008 |